Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing

Hydroxychloroquine (HCQ) is a promising candidate for Coronavirus disease of 2019 (COVID‐19) treatment. The optimal dosing of HCQ is unknown. Our goal was to integrate historic and emerging pharmacological and toxicity data to understand safe and efficacious HCQ dosing strategies for COVID‐19 treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia‐Cremades, Maria, Solans, Belen P., Hughes, Emma, Ernest, Jacqueline P., Wallender, Erika, Aweeka, Francesca, Luetkemeyer, Anne F., Savic, Radojka M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262072/
https://www.ncbi.nlm.nih.gov/pubmed/32285930
http://dx.doi.org/10.1002/cpt.1856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262072/
https://www.ncbi.nlm.nih.gov/pubmed/32285930
http://dx.doi.org/10.1002/cpt.1856

Ejemplares similares